# Rajinder S. Shiwach, M.D., Desoto, TX – FDA Inspections

Source: https://www.keypedia.com/companies/rajinder-s-shiwach-md/1c35f8c6-ef47-4802-b976-011300458fec

> Inspection records and compliance data for Rajinder S. Shiwach, M.D. in Desoto, Texas. 5 FDA inspections on record, 2 Form 483s, last inspected June 11, 2025.

---

## Details

- Name: Rajinder S. Shiwach, M.D.
- FEI Number: 3008981435
- Business Operations: CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY
- Address Line 1: Insite Clinical Research, 941 York Dr Ste 205
- City: Desoto
- State: Texas
- Zip Code: 75115
- Country Name: United States
- Address: Insite Clinical Research, 941 York Dr Ste 205, Desoto, Texas 75115, United States
- Country: United States

## Related Documents

- [483 - Rajinder S. Shiwach, M.D. - 2025-06-11](https://www.keypedia.com/records/483/rajinder-s-shiwach-md/bf794813-f214-49b3-a835-b8ffb75d0ee6) — source: FDA, date: June 11, 2025
- [FDA Inspection 1273540 - Rajinder S. Shiwach, M.D. - 2025-06-11](https://www.keypedia.com/records/fda_inspections/rajinder-s-shiwach-md/728cfe4e-05e3-4d7e-a78f-5b32a7846b39) — classification: No Action Indicated (NAI), source: FDA, date: June 11, 2025
- FDA Inspection 1273540 - Rajinder S. Shiwach, M.D. - 2025-06-11 — classification: No Action Indicated (NAI), source: FDA, date: June 11, 2025
- [FDA Inspection 1237988 - Rajinder S. Shiwach, M.D. - 2024-04-25](https://www.keypedia.com/records/fda_inspections/rajinder-s-shiwach-md/7aef77d2-1916-4a8b-926c-80ad4271025c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 25, 2024
- [FDA Inspection 995066 - Rajinder S. Shiwach, M.D. - 2016-10-21](https://www.keypedia.com/records/fda_inspections/rajinder-s-shiwach-md/af3897f5-c2df-4685-951c-6314b46b5500) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 21, 2016
- [FDA Inspection 843866 - Rajinder S. Shiwach, M.D. - 2013-08-12](https://www.keypedia.com/records/fda_inspections/rajinder-s-shiwach-md/663274c4-df4e-4716-934c-ac4dfbf0ee31) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 12, 2013
- [FDA Inspection 741073 - Rajinder S. Shiwach, M.D. - 2011-08-16](https://www.keypedia.com/records/fda_inspections/rajinder-s-shiwach-md/e39b493c-4b1d-4aba-ab4d-4c9ebb2a2472) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 16, 2011

## Related Companies

- [Amneal Pharmaceuticals, Llc](https://www.keypedia.com/companies/amneal-pharmaceuticals-llc/1727fcb2-2120-4a7c-a93b-a52aa106268f)
- [Arifulla Khan MD](https://www.keypedia.com/companies/arifulla-khan-md/311edd91-40e3-4296-9283-8ea2b60de005)
- [Upsher-Smith Laboratories, LLC](https://www.keypedia.com/companies/upsher-smith-laboratories-llc/abe71588-9a29-43ec-9663-eabd373c78c5)
- [Ascend Laboratories, LLC](https://www.keypedia.com/companies/ascend-laboratories-llc/13da97c0-bcd0-4d01-9c02-8a46b089cfc5)
- [Dario D. Altamirano, DO](https://www.keypedia.com/companies/dario-d-altamirano-do/3edb2aaf-26c5-417d-bd2a-35cb8d56cfc2)
- [Dakhil, Dr Shaker](https://www.keypedia.com/companies/dakhil-dr-shaker/ff880691-4af7-4e7b-ac3d-7c9c33c6bc2a)
- [Imaging Endpoints II, LLC.](https://www.keypedia.com/companies/imaging-endpoints-ii-llc/fcd4f5a9-856c-404f-b6f1-0fa2cb3c88f7)
- [Andrew C Sedillo, MD](https://www.keypedia.com/companies/andrew-c-sedillo-md/4d92fceb-05ed-4140-ab2f-36edf0630a9f)
- [Pharmacyclics LLC](https://www.keypedia.com/companies/pharmacyclics-llc/ac914c47-3023-4974-a8f2-6241d0db58b8)
- [Janssen Pharmaceuticals, dba Actelion Pharmaceutical](https://www.keypedia.com/companies/janssen-pharmaceuticals-dba-actelion-pharmaceutical/8d00c775-7a8c-41d5-aa2d-f2154459469d)

## Related Officers

- [investigator](https://www.keypedia.com/people/travis-m-beard/a89f6d0b-dc5b-4adc-84f5-36e04b00fc2d)
